Abstract
Neonatal apneas and hypopneas present a serious risk for healthy infant development. Treating these adverse events requires frequent manual stimulation by skilled personnel, which can lead to alert fatigue. Automatically predicting these adverse events before they occur would enable the use of methods for automatic intervention. In this work, we propose a neural additive model to predict individual events of neonatal apnea and hypopnea and apply it to a physiological dataset from infants with Robin sequence at risk of upper airway obstruction. The dataset will be made publicly available together with this study. Our model achieved an average area under the receiver operating characteristic curve of 0.80 by additively combining information from different modalities of the respiratory polygraphy recording. This permits the prediction of individual apneas and hypopneas up to 15 seconds before they occur. Its additive nature makes the model inherently interpretable, which allowed insights into how important a given signal modality is for prediction and which patterns in the signal are discriminative. For our problem of predicting apneas and hyponeas in infants with Robin sequence, prior irregularities in breathing-related modalities as well as decreases in SpO2 levels were especially discriminative.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the German Research Foundation (DFG) through Germany's Excellence Strategy (EXC-Number 2064/1, Project number 390727645). The funder played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the University Hospital Tübingen gave ethical approval for this work. Application number: 352/2021BO2
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
